Evidence map›Paper›PMID 32363773›Full record

ArticleBrain and behavior2020

Effect of Sox10 on remyelination of the hippocampus in cuprizone-induced demyelinated mice.

Yu Shao, Juan Ding, Qian-Xiong He, Quan-Rui Ma, Qiang Liu, Chun Zhang, Hao-Wen Lv, Juan Liu

Open access · goldAbstract read
In one paragraph

Article in Brain and behavior, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Remyelination in Multiple Sclerosis: Findings in the Cuprizone Model.International journal of molecular sciences · 2022
    Review
  5. Article
  6. Activation of AExperimental and therapeutic medicine · 2022
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yu ShaoSchool of Basic Medical Sciences, Ningxia Medical University, Yinchuan, China.
Juan DingSchool of Basic Medical Sciences, Ningxia Medical University, Yinchuan, China.
Qian-Xiong HeSchool of Basic Medical Sciences, Ningxia Medical University, Yinchuan, China.
Quan-Rui MaSchool of Basic Medical Sciences, Ningxia Medical University, Yinchuan, China.
Qiang LiuSchool of Basic Medical Sciences, Ningxia Medical University, Yinchuan, China.
Chun ZhangNingxia Key Laboratory of Cerebrocranial Diseases, Ningxia Medical University, Yinchuan, China.
Hao-Wen LvSchool of Basic Medical Sciences, Ningxia Medical University, Yinchuan, China.
Juan LiuSchool of Basic Medical Sciences, Ningxia Medical University, Yinchuan, China.ORCID 0000-0002-2434-3513
Ningxia Medical University · CN

Funding

National Natural Science Foundation of China 81460214Natural Science Foundation of Ningxia 2018AAC02005Ningxia High School first-class Disciplines NXYLXK2017B07
6 · The paper itself

Abstract

objectiveThe low number of oligodendrocytes (OLs) in the hippocampus of patients with schizophrenia suggests that hippocampal demyelination is changed in this condition. Sox10 is expressed throughout OL development. The effect of Sox10 on myelin regeneration is unknown. This study aimed to analyze changes in Sox10 expression in the hippocampus and its regulatory role in hippocampal myelin regeneration in a mouse model of demyelination.

methodsMice were fed 0.2% cuprizone (CPZ) for six weeks to establish the acute demyelinating model (CPZ mice). Behavioral changes of these mice were assessed via open field and tail suspension tests. The ultrastructure of the myelin sheaths in the hippocampus was observed by transmission electron microscopy. The expression levels of myelin sheath-related proteins and the transcription factor Sox10 were detected via immunohistochemistry and Western blots. Furthermore, Sox10-overexpressing adeno-associated virus was injected into the hippocampus after establishing the demyelinating model to investigate effects of Sox10 on remyelination.

resultsCPZ mice showed abnormal behavioral changes, a large number of pathological changes in the myelin sheaths, and significantly reduced protein expression of the myelin sheath markers myelin basic protein and proteolipid protein. This confirmed that the demyelinating model was successfully established. Meanwhile, the protein expression of the oligodendrocyte precursor cell marker neural/glial antigen 2 (NG2) increased, whereas Sox10 expression decreased. After Sox10 overexpression in the hippocampus, the abnormal behavior was improved, the ultrastructure of the myelin sheaths was restored, and the expression of myelin sheath protein was reversed. NG2 expression was upregulated.

conclusionOverexpression of Sox10 promotes hippocampal remyelination after CPZ-induced acute demyelination.

Indexed as

Demyelinating DiseasesRemyelinationAnimalsCuprizoneDisease Models, AnimalHippocampusMaleMiceMice, Inbred C57BLMice, Inbred ICRMyelin SheathOligodendrogliaSOXE Transcription FactorsCuprizoneSox10 protein, mouseSOXE Transcription FactorsdemyelinationhippocampusremyelinationSox10

Identifiers

PMID32363773
PMCPMC7303379
OpenAlexW3022358477

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.